Federal budget negotiations are already under way.
April 15 marks the 30-Day anniversary of the enactment of the 57% cut to CDMRP including the elimination of all funding to Bone Marrow Failure Research.
Every medical research program at CDMRP directly impacts the health and lives of the U.S. military, their families, veterans, and the public. Research breakthroughs have led to new clinical trials, new drug products, and novel procedures that are making a difference in the everyday lives of patients and families.
Join other Patients and Families in Urging your Members of Congress to restore these research programs, especially those affecting Bone Marrow Failure Diseases.
#restoreCDMRP
The CDMRP is one of the most effective and efficient medical research programs in the country:
• Just 5.62% overhead, among the lowest of all federal research agencies
• High-risk, high-reward science tailored to urgent health needs
• Collaborative, avoiding duplication with NIH and VA
• Responsive, adapting yearly to meet emerging challenges
Its impact is undeniable:
• 56 FDA-approved products, including 11 cancer drugs
• A rapid blood test to detect traumatic brain injury
• 600+ clinical trials for cutting-edge drugs and vaccines
• Treatments for burns, toxic exposure, and addiction